27. Miguel V., Mejias А., Ramilo О., Ardura М., Sanchez PJ. Cytomegalovirus Meningitis in an Infant with Severe Combined Immunodeficiency. J Pediatr. 2016 Jun;173:235-7.
28. Rivers L, Gaspar HB. Severe combined immunodeficiency: recent developments and guidance on clinical management. Arch Dis Child. 2015;100(7):667-72.
29. John S. Bradley, John D. Nelson. Nelson"s Pediatric Antimicrobial Therapy. American Academy of Pediatrics; January 2018
30. Gennery A. Recent advances in treatment of severe primary immunodeficiencies [version 1; referees: 2], F1000 Research 2015, 4(F1000 Faculty Rev):1459.
31. Marciano BE, Holland SM. Primary Immunodeficiency Diseases: Current and Emerging Therapeutics. Front Immunol. 2017 Aug 9;8:937.
32. Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):573-82.
33. Marciano BE, Huang C-Y, Joshi G, N. Rezaei, BC Carvalho, Z. Allwood et. al. BCG vaccination in SCID patients: complications, risks and vaccination policies. J Allergy Clin Immunol. 2014 Apr; 133(4): 1134-1141.
34. Ю.А.Родина, А.Л.Лаберко, Г.Г.Солопова,Д.Н.Балашов, А.Ю.Щербина. БЦЖ- ассоциированный синдром активации макрофагов у пациентов с тяжело комбинированной иммунной недостаточностью после трансплантации гемопоэтических стволовых клеток. Вопросы гематологии/онкологии и иммунопатологии в педиатрии, 2016, т. 15, №1, с. 82
35. Brady MT, Byington CL, Davies HD, Edwards KM, Jackson MA, Maldonado YA et. al. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014 Aug;134(2):620-38.
36. Aguilar C, Malphettes M, Donadieu J, Chandesris O, Coignard-Biehler H, Catherinot E et al. Prevention of infections during primary immunodeficiency. Clin Infect Dis. 2014 Nov 15;59(10):1462-70.
37. Walter JE, Farmer JR, Foldvari Z, Torgerson TR, Cooper MA. Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies. J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1089-1100.
38. Pariyaprasert W, Pacharn P, Visitsunthorn N, Chokephaibulkit K, Sanpakit K, Viprakasit V et. al. Successful treatment of disseminated BCG infection in a SCID patient with granulocyte colony stimulating factor. Asian Pac J Allergy Immunol. 2008 Mar;26(1):71-5.
39. Stephanie Albin, Charlotte Cunningham-Rundles. An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. Immunotherapy. 2014; 6(10): 1113-1126.
40. Shapiro RS, Borte M. 7th International Immunoglobulin Conference: Immunoglobulin in clinical practice. Clin Exp Immunol. 2014 Dec;178 Suppl 1:65-6.
41. Elena E. Perez, Jordan S. Orange, Francisco Bonilla, Javier Chinen, Ivan K. Chinn. Update on the use of immunoglobulin in human disease: A review of evidence. JCI, 2017 Mar; vol. 139 (3): 146.
42. Nicholas Brodszki, Dominik Turkiewicz, Jacek Toporski, Lennart Truedsson, Josefina Dykes. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions. Orphanet Journal of Rare Diseases, 2016, 11:5.
43. Uhlin M, Gertow J, Uzunel, Okas M, Berglund S, Watz E et. al. Rapid salvage treatment with virus-specific T cells for therapy-resistant disease. Clin Infect Dis. 2012 Oct;55(8):1064-73.
44. Bao L, Cowan MJ, Dunham K, Horn B, McGuirk J, Gilman A, Lucas KG. Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections. J Immunother. 2012 Apr;35(3):293-8.
45. Руководство по применению компонентов донорской крови. ГОСТ 52938-2008. Гематологический научный центр РАМН.
46. EBMT/ESID guidelines for haematopoietic stem cell transplantation for primary immunodeficiencies.https://esid.org/Working-Parties/Inborn-Errors-Working-Party-IEWP/Resources.
47. И.В. Кондратенко, О.Е. Пащенко, Ю.А. Родина, М.В. Белевцев, M. van den Burg, А.А. Бологов. Клинико-лабораторные фенотипы тяжелых комбинированных иммунодефицитов, вызванных мутациями генов RAG1/RAG2. Аллергология и иммунология в педиатрии, 2012.-N 3.- С.13-20.
48. А.Л.Лаберко, М.А.Масчан, Л.Н.Шелихова, Ю.В.Скворцова, И.П.Шипицына, Е.И.Гутовская, И.Н.Смирнова, Ю.А.Родина, Е.В.Дерипапа, С.А.Дибирова, И.Г.Хамин, Г.А.Новичкова, А.А.Масчан, А.Ю.Щербина, . Д.Н.Балашов. Опыт применения TCRae+ и CD19+ деплеции при неродственных и гаплоидентичных трансплантациях гемопоэтических стволовых клеток у детей с первичными иммунодефицитными состояниями. Вопросы гематологии/ онкологии и иммунопатологии в педиатрии, 2016, т. 15, №1, с. 72-80.
49. Cavazzana-Calvo М., AndrtS-Schmutz I., Fischer A. Haematopoietic stem cell transplantation for SCID patients: where do we stand? Br. J. Haematol, 2013 Jan; 160( 2): 146-152.